Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy
Limitations in inflammatory bowel disease (IBD) care necessitate greater patient activation and self-efficacy, measures associated with positive health outcomes.
We assessed change in patient activation and general self-efficacy from baseline to 12 months through our TELEmedicine for IBD trial, a multicenter, randomized controlled trial consisting of a web-based monitoring system that interacts with participants via text messaging. A total of 222 adults with IBD who had experienced an IBD flare within 2 years prior to the trial were randomized into either a control arm that received standard care (SC) or an intervention arm that completed self-testing through the TELE-IBD system every other week (EOW) or weekly (W).
Changes in self-efficacy scores were not significantly different between control and experimental groups. Patient activation scores were significantly different between standard care and the TELE-IBD EOW group only (p = 0.03).
Use of remote monitoring did not improve self-efficacy or patient activation compared to routine care.
KeywordsTelemedicine Inflammatory bowel disease Patient activation Self-efficacy
This research was supported by the Agency for Healthcare Research and Quality (1R01HS018975-01A1) and the University of Maryland General Clinical Research Centers Program. Zaid Bilgrami was supported by the Program for Research Initiated by Students and Mentors (PRISM) at the University of Maryland School of Medicine.
Compliance with ethical standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 1.Dahlhamer JM. Prevalence of inflammatory bowel disease among adults aged ≥ 18 years—United States, 2015: MMWR. Morbidity and mortality weekly report; 2016;65.Google Scholar
- 20.Kim JY, Wineinger NE, Steinhubl SR. The influence of wireless self-monitoring program on the relationship between patient activation and health behaviors, medication adherence, and blood pressure levels in hypertensive patients: a substudy of a randomized controlled trial. J Med Internet Res. 2016;18:e116.CrossRefGoogle Scholar
- 21.Oddone EZ, Gierisch JM, Sanders LL, et al. A coaching by telephone intervention on engaging patients to address modifiable cardiovascular risk factors: a randomized controlled trial. J Gen Intern Med. 2018;7:1–8.Google Scholar
- 30.Schwarzer R, Jerusalem M. Generalized self-efficacy scale. In: Weinman J, Wright S, Windsor JM, eds. Measures in Health Psychology: A User’s Portfolio. Causal and Control Beliefs. Berkshire: NFER-NELSON; 1995:35.Google Scholar
- 31.Insigina Health. Patient activation measure (PAM) 13 TM License Materials copyright. Portland: Insigna Health LLC; 2011.Google Scholar